Treace Medical Introduces IntelliGuide™ PSI Technology
PONTE VEDRA, Fla. — Treace Medical Concepts, Inc. (Nasdaq: TMCI) is leading a significant advancement in the surgical management of midfoot deformities. The company has successfully completed the first cases utilizing their innovative IntelliGuide™ patient-specific instrumentation (PSI) integrated with the Adductoplasty® System, designed to provide tailored corrections based on individual patient needs.
What is IntelliGuide™ PSI?
The IntelliGuide™ PSI, featuring the groundbreaking RedPoint™ technology, stands as the first patient-specific surgical guide system in the U.S. specifically created for midfoot and bunion deformities. By converting CT scans into precise surgical plans, the technology produces unique 3D-printed cut guides, enhancing surgical accuracy and personalization during procedures. This innovative approach is particularly crucial, as up to 30% of patients with bunions also experience related midfoot deformities such as metatarsus adductus.
Market Release Plans
Treace Medical is initiating a limited market release of IntelliGuide™ PSI for the Adductoplasty® Procedure. This progressive rollout will increase surgical access to IntelliGuide™ in conjunction with both the Lapiplasty® and Adductoplasty® methods. Complete market availability is anticipated within the first half of the upcoming year.
Industry Leader's Insights
John T. Treace, the CEO and founder of Treace Medical, emphasized the significance of IntelliGuide™ PSI in further establishing the company’s leadership in the realm of bunion and midfoot surgery. He stated, “This technology elevates the benefits of patient-specific instrumentation, allowing us to provide a more comprehensive solution that meets the diverse needs of surgeons and their patients.”
Surgeons Embrace New Technology
Eric Kuhlman, DPM at the Center for Spine & Orthopedics, expressed excitement about the IntelliGuide™ technology. He remarked that virtual planning and the use of 3D-printed guides offer unprecedented intra-operative precision. This development, he believes, will revolutionize treatment methods for bunion-related midfoot deformities.
About Treace Medical Concepts
Treace Medical Concepts, Inc. is committed to raising the bar in the surgical treatment of bunions and associated midfoot deformities. With approximately 67 million Americans affected by bunions, the company has focused on creating solutions to meet this demand, particularly for the estimated 1.1 million patients eligible for surgery each year. Treace has pioneered groundbreaking systems like Lapiplasty® 3D Bunion Correction® and the newly introduced Adductoplasty® Midfoot Correction System.
The introduction of SpeedPlate™ Rapid Compression Implants is further evidence of Treace's dedication to innovation, providing versatile fixation options across various procedures.
Connect with Treace Medical
To stay updated on the latest developments at Treace Medical, visit their official website and engage with them on social platforms such as LinkedIn, Facebook, and Instagram.
Frequently Asked Questions
What is the IntelliGuide™ PSI technology?
IntelliGuide™ PSI is a patient-specific cut guide system combining AI and 3D printing to enhance surgical precision in correcting midfoot deformities.
When will the full market release of IntelliGuide™ PSI be?
The full market release is expected within the first half of the upcoming year.
How does Treace Medical address midfoot deformities?
Treace focuses on innovative surgical solutions, creating targeted procedures that correct bunions and midfoot deformities using advanced technologies.
Who can benefit from Treace's procedures?
Patients suffering from bunions and related midfoot deformities can benefit from Treace Medical's surgical solutions, particularly those who are surgical candidates.
How many Americans are affected by bunions according to Treace?
Treace estimates that around 67 million Americans are affected by bunions, with a significant portion being eligible for surgical intervention.
